These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2150135)

  • 1. [What clinicians should know about Sestamibi].
    Lette J
    Union Med Can; 1990; 119(6):330. PubMed ID: 2150135
    [No Abstract]   [Full Text] [Related]  

  • 2. Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.
    Bonow RO; Dilsizian V
    J Nucl Med; 1992 May; 33(5):815-8. PubMed ID: 1533248
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thallium-201 and sestamibi: principles and kinetics of the two tracers].
    Parodi O
    G Ital Cardiol; 1991 Aug; 21(8):885-8. PubMed ID: 1837528
    [No Abstract]   [Full Text] [Related]  

  • 4. ECG-gated and static technetium-99m-SESTAMIBI planar myocardial perfusion imaging: a comparison with thallium-201 and study of observer variabilities.
    Verzijlbergen JF; Cramer MJ; Niemeyer MG; Ascoop CA; Van der Wall EE; Pauwels EK
    Am J Physiol Imaging; 1990; 5(2):60-7. PubMed ID: 2147553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of myocardial blood flow by radiolabeled tracers.
    Wilson RA
    J Nucl Med; 1993 Sep; 34(9):1518-9. PubMed ID: 8355073
    [No Abstract]   [Full Text] [Related]  

  • 6. Perfusion scintigraphy and evaluation of myocardial viability.
    McKillop JH
    Nucl Med Commun; 1991 Aug; 12(8):659-62. PubMed ID: 1780107
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments to: Clinical Comparison Between Thallium 201 and Tc-99m-Methoxy Isobutyl Isonitrile (Hexamibi) Myocardial Perfusion Imaging for Detection of Coronary Artery Disease.
    Whalley DR
    Eur J Nucl Med; 1989; 15(12):805. PubMed ID: 2625129
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI).
    Li QS; Solot G; Frank TL; Wagner HN; Becker LC
    J Nucl Med; 1990 Jun; 31(6):1069-76. PubMed ID: 2140856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial perfusion imaging has grown dramatically.
    Berman DS
    Semin Nucl Med; 1991 Jul; 21(3):170-2. PubMed ID: 1835135
    [No Abstract]   [Full Text] [Related]  

  • 10. New agents labelled with technetium 99m for myocardial perfusion imaging.
    Taillefer R
    Can Assoc Radiol J; 1992 Aug; 43(4):258-66. PubMed ID: 1386280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perfusion scintigraphy of the heart].
    van Vlies B; van Royen EA
    Ned Tijdschr Geneeskd; 1991 Sep; 135(37):1681-6. PubMed ID: 1922510
    [No Abstract]   [Full Text] [Related]  

  • 12. [Technetium-99m isonitrile versus thallium 201 in coronary disease].
    Candell Riera J; Aguadé Bruix S; Castell Conesa J; Cortadellas Angel J
    Rev Esp Cardiol; 1994; 47 Suppl 4():101-15. PubMed ID: 7863075
    [No Abstract]   [Full Text] [Related]  

  • 13. Technetium-labeled myocardial perfusion agents.
    Heo J; Iskandrian AS
    Cardiol Clin; 1994 May; 12(2):187-98. PubMed ID: 8033172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison between myocardial perfusion scintigraphy with thallium-201 and technetium-99m-Sestamibi (methoxy isobutyl isonitrile) for the detection of coronary atherosclerotic disease].
    Taillefer R; Lambert R; Grégoire J; Essiambre R; Phaneuf DC
    Union Med Can; 1990; 119(6):322, 324, 326-9. PubMed ID: 2150134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease.
    Taillefer R; Lambert R; Essiambre R; Phaneuf DC; Léveillé J
    J Nucl Med; 1992 Jun; 33(6):1091-8. PubMed ID: 1534575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of planar technetium-99m-sestamibi myocardial perfusion images using modified background subtraction.
    Koster K; Wackers FJ; Mattera JA; Fetterman RC
    J Nucl Med; 1990 Aug; 31(8):1400-8. PubMed ID: 2143529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA approves two new technetium-labeled cardiac agents and a pharmacologic alternative to exercise in stress-thallium studies.
    Ghosh PR
    J Nucl Med; 1991 May; 32(5):11N, 14N-16N, 19N. PubMed ID: 1827149
    [No Abstract]   [Full Text] [Related]  

  • 18. Tracer selection with different stress modalities based on tracer kinetics.
    Heller GV
    J Nucl Cardiol; 1996; 3(6 Pt 2):S15-21. PubMed ID: 8989682
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of myocardial viability by isotopic methods].
    Latre Romero JM; Vallés Belsué F
    Rev Esp Cardiol; 1994; 47 Suppl 4():116-23. PubMed ID: 7863076
    [No Abstract]   [Full Text] [Related]  

  • 20. Technetium-99m-sestamibi: another window on myocardial viability?
    Liu P
    J Nucl Med; 1991 Feb; 32(2):298-9. PubMed ID: 1825112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.